ProShare Advisors
GEN

ProShare Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

ProShare Advisors’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-11,354
Closed -$19K – 1735
2019
Q4 		$19K Buy
+11,354
New +$17K ﹤0.01% 1780

Other funds holding GEN

VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

ProShare Advisors's GEN Position: Q1 2020 in Review

ProShare Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q1 2020, closing a stake of 11,354 shares — an estimated $19K sold.

ProShare Advisors first reported a position in GEN in Q4 2019 and held it in 1 quarter. The position peaked at $19K in Q4 2019. 67 funds tracked by Wall St. Rank hold GEN as of Q1 2020.

  • ProShare Advisors reported no remaining Genesis Healthcare, Inc. position as of Q1 2020 after selling out during the quarter.
  • ProShare Advisors sold 11,354 Genesis Healthcare, Inc. shares in Q1 2020, an estimated $19K.
  • ProShare Advisors first reported a position in Genesis Healthcare, Inc. in Q4 2019 and held it in 1 quarter.
  • ProShare Advisors's Genesis Healthcare, Inc. position peaked at $19K in Q4 2019.
  • 67 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2020.

Based on ProShare Advisors's 13F filing for Q1 2020, filed 15 May 2020.